国家医保局支持脑机接口等新技术进入临床并收费

Group 1 - The National Healthcare Security Administration (NHSA) has established a new pricing mechanism for newly launched drugs to support innovation in pharmaceuticals and medical devices [1] - Over 100 pricing items related to new medical technologies have been added, facilitating the revenue return for urgently needed new products [1] - The NHSA aims to create a parallel structure of "pricing project establishment and technological innovation" through the introduction of 30 batches of project guidelines [1] Group 2 - Unified pricing items have been established for neurological system project guidelines, including "brain-machine interface implantation fee" and "brain-machine interface adaptation fee," allowing for rapid clinical application once the technology is approved [2] - For ear, nose, and throat project guidelines, pricing items such as "artificial cochlear implantation fee" and "speech device installation fee" have been introduced to encourage healthcare institutions to assist more patients [2] - Pricing items for radiation therapy project guidelines include "proton therapy" and "heavy ion therapy," promoting the clinical application of advanced medical equipment [2]